Skip to main content
Clinical Trials/NCT06133660
NCT06133660
Completed
Not Applicable

Influence of Intravitreal Aqueous Tamponade on Lens Status and Ocular

Bo Jia1 site in 1 country21 target enrollmentStarted: October 30, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Bo Jia
Enrollment
21
Locations
1
Primary Endpoint
lens thickness

Overview

Brief Summary

To observe the effects of vitreous cavity Balanced salt solution (BSS) tamponade on the state of the lens and related parameters of the eye, and whether the changes of the above parameters are correlated with age, gender, diabetes or not, etc., so as to provide references for the diagnosis and treatment of related diseases and scientific research.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
16 Years to 65 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ① Patients undergoing vitrectomy for diabetic retinopathy, epiretinal membranes, macular hole, retinal detachment, and other diseases;
  • Patients who underwent vitreous silicone oil tamponade and vitreous silicone oil removal due to various causes; ③ Intraoperative BSS was used for fill the vitreous cavity; ④ Before treatment, inform the patient that the clinical data may be used in clinical research, and the patient and his family are informed and sign the informed consent.

Exclusion Criteria

  • ① The operation eye was intraocular lens or cataract extraction during operation; ② Suspensory ligament relaxation or rupture, ciliary body detachment or transaction, lens dislocation, endophthalmitis, traumatic cataract;
  • intraoperative lens injury; ④ patients who refused to participate in the study.

Outcomes

Primary Outcomes

lens thickness

Time Frame: 1 year

degree of lens opacity

Time Frame: 1 year

Secondary Outcomes

  • anterior chamber depth(1 year)
  • axial length(1 year)

Investigators

Sponsor
Bo Jia
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Bo Jia

M.D.

Second Hospital of Jilin University

Study Sites (1)

Loading locations...

Similar Trials